A population-based study of age-related variation in clinicopathological features, molecular markers and outcome from colorectal cancer

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2833-2838

  Morris, Melinda ^a   Platell, Cameron ^a,b   Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

Chemotherapy; CIMP; CIN; HNPCC

Indexed keywords

K RAS PROTEIN; MOLECULAR MARKER; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OUTCOME ASSESSMENT; PATHOLOGY; PRIORITY JOURNAL; RECTUM CANCER; RECTUM TUMOR; TIME SERIES ANALYSIS;

ADULT; AGE FACTORS; AGED; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENES, RAS; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION;

EID: 34547735646     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
2. Jass JR, Whitehall VL, Young J and Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862-876, 2002.
3. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
4. Van Rijnsoever M, Grieu F, Elsaleh H, Joseph D and Iacopetta B: Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51: 797-802, 2002.
5. Delattre O, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, Sastre X, Validire P, Feinberg AP and Thomas G: Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 2(8659): 353-356, 1989.
6. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL and Gaudernack G: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74: 664-669, 1997.
7. Gonzalez EC, Roetzheim RG, Ferrante JM and Campbell R: Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 44: 251-258, 2001.
8. Iacopetta B: Are there two sides to colorectal cancer?: Int J Cancer 101: 403-408, 2002.
9. Gervaz P, Bucher P and Morel P: Two colons - two cancers: paradigm shift and clinical implications. J Surg Oncol 88: 261-266, 2004.
10. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York, Springer, pp. 113-124, 2002.
11. Iacopetta B and Grieu F: Routine detection of the Replication Error phenotype in clinical tumor specimens using fluorescence-SSCP. BioTechniques 28: 566-570, 2000.
12. Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J and Iacopetta B: BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Molecular Cancer 5: 2, 2006.
13. Wang C, van Rijnsoever M, Grieu F, Bydder S, Elsaleh H, Joseph D, Harvey J and Iacopetta B: Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer. Oncology 64: 259-265, 2003.
14. Iacopetta B, Elsaleh H, Grieu F, Joseph D, Sterrett G and Robbins P: Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism. Diagnostic Molecular Pathology 9: 20-25, 2000.
15. Matanoski G, Tao XG, Almon L, Adade AA and Davies-Cole JO: Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer 107: 1112-1120, 2006.
16. Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS and Wang SM: Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 90: 205-214, 2003.
17. Lin JT, Wang WS, Yen CC, Liu JH, Yang MH, Chao TC, Chen PM and Chiou TJ: Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 6: 900-905, 2005.
18. O'Connell JB, Maggard MA, Livingston EH and Yo CK: Colorectal cancer in the young. Am J Surg 187: 343-348, 2004.
19. Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C and Faivre J: Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum 44: 380-387, 2001.
20. Chung YF, Eu KW, Machin D, Ho JM, Nyam DC, Leong AF, Ho YH and Seow-Choen F: Young age is not a poor prognostic marker in colorectal cancer. Br J Surg 85: 1255-1259, 1998.
21. Kam MH, Eu KW, Barben CP and Seow-Choen F: Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis 6: 191-194, 2004.
22. Lee PY, Fletcher WS, Sullivan ES and Vetto JT: Colorectal cancer in young patients: characteristics and outcome. Am Surg 60: 607-612, 1994.
23. Heys SD, O'Hanrahan TJ, Brittenden J and Eremin O: Colorectal cancer in young patients: a review of the literature. Eur J Surg Oncol 20: 225-231, 1994.
24. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR and Leggett BA: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144, 2004.
25. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M and Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77, 2000.
26. Losi L, Di Gregorio C, Pedroni M, Ponti G, Roncucci L, Scarselli A, Genuardi M, Baglioni S, Marino M, Rossi G, Benatti P, Maffei S, Menigatti M, Roncari B and Ponz de Leon M: Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am J Gastroenterol 100: 2280-2287, 2005.
27. Suh JH, Lim SD, Kim JC, Hong SH and Kang GH: Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum 45: 219-228, 2002.
28. Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John DJ, Macrae FA, Giles GG and Hopper JL: Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23: 6524-6532, 2005.
29. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N and TP53-CRC Collaborative Study Group: The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of TP53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23: 7518-7528, 2005.
30. Alsop K, Mead L, Smith LD, Royce SG, Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, Hopper JL and Southey MC: Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer 42: 1357-1361, 2006.
31. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH and Kim YS: BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10: 191-195, 2004.
32. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, Wolff RK and Slattery ML: Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837-845, 2005.
33. Shpitz B, Millman M, Ziv Y, Klein E, Grankin M, Gochberg S, Sandbank J, Halevi A, Bernheim J, Khromov Y, Gutman M and Sayfan J: Predominance of younger age, advanced stage, poorly-differentiated and mucinous histology in Israeli Arab patients with colorectal cancer. Anticancer Res 26: 533-537, 2006.